Global Biosimilar Interleukins Market Size

How Will The Biosimilar Interleukins Market Grow In 2022?

Avail a limited period discount of 33% on our uniquely designed Opportunities and Strategies market research reports. Contact us today and make winning strategies!


The biosimilar interleukins market is forecasted to achieve exponential growth in the coming few years with a forecast CAGR (compound annual growth rate) of more than 39%, as per The Business Research Company’s market report!


Read More On The Biosimilar Interleukins Market Report 2022 –


The Biosimilar Interleukins Market Size In 2022 And Forecast

The global biosimilar interleukins market is expected to grow from $1.42 billion in 2021 to $2.01 billion in 2022 at a compound annual growth rate (CAGR) of 40.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, affecting many markets across the globe. The biosimilar interleukins market is expected to reach $7.52 billion in 2026 at a CAGR of 39.1%.

The biosimilar interleukins market consists of sales of interleukin biosimilars generated by the establishments that manufacture interleukin biosimilars that are used to treat various autoimmune diseases.


Request for A Free Sample Of The Global Biosimilar Interleukins Market Report:


Increase In The Prevalence Of Autoimmune Diseases Is Driving The Growth Of The Biosimilar Interleukins Market

According to the Johns Hopkins University report published in 2021, autoimmune illnesses impacted around 3% of the population in the United States, or about 10 million individuals. Therefore, the increasing prevalence of autoimmune diseases is increasing the demand for the biosimilar interleukins market and is expected to drive the growth of the market.


Competitive Landscape And The Regional Analysis Of The Biosimilar Interleukins Market

Major players in the biosimilar interleukins market are MabPharm, Gedeon Richter, Bio-Thera Solutions, Sorrento Therapeutics/MabTech, and Sunshine Guojian Pharmaceutical.


The Biosimilar Interleukins Global Market Report 2022  covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the biosimilar interleukins market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the biosimilar interleukins market.


Biosimilar Interleukins Market Segmentation By The Business Research Company

1) By Type: IL-17, IL-23, IL-1, IL-5, IL-6

2) By Application: Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Asthma, Inflammatory Bowel Disease (IBD), Others

3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Clinics, Research Institutes


Here Are Some Reports Related To The Biosimilar Interleukins Market –

Biosimilar Growth Hormones Global Market Report 2022

Biosimilar Lymphocyte Modulator Global Market Report 2022

Biosimilar Hormones Global Market Report 2022


Get In Touch With Us – Call us at:

Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Found this article helpful? Share it on: